MedPath

iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study

Conditions
Glaucoma, Open-Angle
Registration Number
NCT04624685
Lead Sponsor
Glaukos Corporation
Brief Summary

Long term follow up of subjects in the IDE study for iStent Inject to monitor safety

Detailed Description

To evaluate the long -term rate of clinically relevant complications associated with iStent inject® placement and stability in subjects who have completed participation of the IDE clinical trial (GC-008).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
475
Inclusion Criteria
  • Randomized subject followed for 24 months in the GC-008 study
  • Able to understand study requirements
  • Willing to attend scheduled follow-up exams for 5 years post-operatively
  • Able and willing to provide written informed consent on the IRB approved Informed Consent Form
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
iStent inject Placement and Stability60 Months

Rate of clinically relevant complications associated with iStent inject placement and stability.

Secondary Outcome Measures
NameTimeMethod
Sight-Threatening Adverse Events60 Months

Rate of occurrence of sight-threatening adverse events

Trial Locations

Locations (24)

Arizona Advanced Eye Research Institute

🇺🇸

Glendale, Arizona, United States

Vold Vision, PLLC

🇺🇸

Fayetteville, Arkansas, United States

North Bath Eye Associates, Inc.

🇺🇸

Santa Rosa, California, United States

Eye Center of northern Colorado, PC

🇺🇸

Fort Collins, Colorado, United States

Argus Research

🇺🇸

Cape Coral, Florida, United States

International Research Center

🇺🇸

Tampa, Florida, United States

Center for Sight

🇺🇸

Venice, Florida, United States

Clayton Eye Clinical Research, LLC.

🇺🇸

Morrow, Georgia, United States

Chicago Eye Specialists

🇺🇸

Chicago, Illinois, United States

Arbor Center for Eye Care

🇺🇸

Orland Park, Illinois, United States

Scroll for more (14 remaining)
Arizona Advanced Eye Research Institute
🇺🇸Glendale, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.